I read the article by Kilincalp et al. (2014) with great interest. They assessed platelet indices including platelet counts, mean platelet volume (MPV), and inflammatory markers, including the neutrophil/lymphocyte ratio and the platelet/ lymphocyte ratio, for the preoperative diagnosis of colorectal cancer and their usefulness in the follow-up of colorectal cancer. Platelet counts, MPV, neutrophil/lymphocyte ratio, and the platelet/lymphocyte ratio were significantly higher in colorectal cancer patients preoperatively compared with healthy participants. Surgical tumor resection resulted in a significant decrease in the neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and MPV. This is a well-written study. However, many confounding factors can affect MPV values. Therefore, I wish to highlight these issues.
In addition to cardiovascular and cerebrovascular diseases, many cardiovascular risk factors can affect MPV such as obesity, hypertension, smoking, hyperlipidemia, diabetes mellitus, prediabetes, atrial fibrillation, metabolic syndrome, fatty liver disease, and rheumatic and inflammatory chronic diseases (Vizioli et al., 2009; Gasparyan et al., 2011; Varol et al., 2013) . In this age group, it is expected that some patients will have these comorbid conditions. The authors did not report the BMI, blood pressure values, smoking status, blood lipid and glucose levels, and other mentioned comorbidities in patients and controls. In addition, some antihypertensive drugs such as calcium antagonists and β-blockers can also influence MPV (Celik et al., 2007; Demirtunc et al., 2007) .
There are also no data on drugs. These factors should be taken into account for accurate MPV assessments. It would have been better if the authors had provided this information.
The MPV is a measurement of the platelet volume that is included within full blood count parameters. When compared with smaller ones, larger platelets aggregate more rapidly with collagen, have more granules, express more glycoprotein Ib and IIb/IIIa receptors, and moreover have higher thromboxane A2 levels (Vizioli et al., 2009; Gasparyan et al., 2011) . Previous studies have shown that many cardiovascular risk factors can affect MPV. Because of this, all confounding factors should be taken into account.
